Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

pembrolizumab 37 Carboplatin 31 Cisplatin 30 Paclitaxel 23 Nivolumab 21 Pemetrexed 21 Dexamethasone 18 Gemcitabine 18 Ipilimumab 15 Docetaxel 13 Fluorouracil 13 Capecitabine 12 Rituximab 12 Cyclophosphamide 10 Cytarabine 10 olaparib 10 Trastuzumab 9 atezolizumab 9 daratumumab 9 durvalumab 9 130-nm albumin-bound paclitaxel 8 Bevacizumab 8 Lenalidomide 8 Prednisone 8 trastuzumab deruxtecan 8 Bortezomib 7 Fulvestrant 7 Oxaliplatin 7 Vinorelbine 7 cabozantinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Has announcements × recombinant FVIIa × Clear all

NCT02622321 2021-06-24

HAVEN 1

Hoffmann-La Roche

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡